These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21091250)

  • 1. Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial.
    Cicero AF; Rosticci M; Veronesi M; Bacchelli S; Strocchi E; Melegari C; Grandi E; Borghi C
    J Med Food; 2010 Dec; 13(6):1363-8. PubMed ID: 21091250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial.
    Cicero AF; Rosticci M; Gerocarni B; Bacchelli S; Veronesi M; Strocchi E; Borghi C
    Hypertens Res; 2011 Sep; 34(9):1035-40. PubMed ID: 21753776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of the short-term effect of isoleucine-proline-proline/valine-proline-proline lactotripeptides from casein on office and ambulatory blood pressure in subjects with pharmacologically untreated high-normal blood pressure or first-degree hypertension.
    Cicero AF; Rosticci M; Ferroni A; Bacchelli S; Veronesi M; Strocchi E; Borghi C
    Clin Exp Hypertens; 2012; 34(8):601-5. PubMed ID: 22574612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial.
    Cicero AF; Colletti A; Rosticci M; Cagnati M; Urso R; Giovannini M; Borghi C; D'Addato S
    Metab Syndr Relat Disord; 2016 Apr; 14(3):161-6. PubMed ID: 26683986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Val-Pro-Pro and Ile-Pro-Pro on nondipper patients: a preliminary study.
    Kurosawa MT; Nakamura Y; Yamamoto N; Yamada K; Iketani T
    J Med Food; 2011 May; 14(5):538-42. PubMed ID: 21480799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial.
    Engberink MF; Schouten EG; Kok FJ; van Mierlo LA; Brouwer IA; Geleijnse JM
    Hypertension; 2008 Feb; 51(2):399-405. PubMed ID: 18086944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study.
    Nakamura T; Mizutani J; Sasaki K; Yamamoto N; Takazawa K
    J Med Food; 2009 Dec; 12(6):1221-6. PubMed ID: 19821692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red wine polyphenols do not lower peripheral or central blood pressure in high normal blood pressure and hypertension.
    Botden IP; Draijer R; Westerhof BE; Rutten JH; Langendonk JG; Sijbrands EJ; Danser AH; Zock PL; van den Meiracker AH
    Am J Hypertens; 2012 Jun; 25(6):718-23. PubMed ID: 22421906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement.
    Jauhiainen T; Vapaatalo H; Poussa T; Kyrönpalo S; Rasmussen M; Korpela R
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1600-5. PubMed ID: 16364832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blood pressure lowering effect of lactotripeptides and salt intake in 24-h ambulatory blood pressure measurements.
    Yamasue K; Morikawa N; Mizushima S; Tochikubo O
    Clin Exp Hypertens; 2010 Jul; 32(4):214-20. PubMed ID: 20608891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an excess intake of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro in subjects with normal blood pressure, high-normal blood pressure, or mild hypertension.
    Ishida Y; Shibata Y; Fukuhara I; Yano Y; Takehara I; Kaneko K
    Biosci Biotechnol Biochem; 2011; 75(3):427-33. PubMed ID: 21389626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term intake of lactotripeptides on cardiovascular risk factors in hypertensive subjects.
    Jauhiainen T; Niittynen L; Orešič M; Järvenpää S; Hiltunen TP; Rönnback M; Vapaatalo H; Korpela R
    Eur J Clin Nutr; 2012 Jul; 66(7):843-9. PubMed ID: 22617279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension.
    Mizuno S; Matsuura K; Gotou T; Nishimura S; Kajimoto O; Yabune M; Kajimoto Y; Yamamoto N
    Br J Nutr; 2005 Jul; 94(1):84-91. PubMed ID: 16115337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: a randomized, double-blind, placebo-controlled trial.
    Nakamura T; Mizutani J; Ohki K; Yamada K; Yamamoto N; Takeshi M; Takazawa K
    Atherosclerosis; 2011 Nov; 219(1):298-303. PubMed ID: 21723554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
    Pilz S; Gaksch M; Kienreich K; Grübler M; Verheyen N; Fahrleitner-Pammer A; Treiber G; Drechsler C; Ó Hartaigh B; Obermayer-Pietsch B; Schwetz V; Aberer F; Mader J; Scharnagl H; Meinitzer A; Lerchbaum E; Dekker JM; Zittermann A; März W; Tomaschitz A
    Hypertension; 2015 Jun; 65(6):1195-201. PubMed ID: 25801871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
    Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
    Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beetroot supplementation lowers daily systolic blood pressure in older, overweight subjects.
    Jajja A; Sutyarjoko A; Lara J; Rennie K; Brandt K; Qadir O; Siervo M
    Nutr Res; 2014 Oct; 34(10):868-75. PubMed ID: 25294299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ile-Pro-Pro and Val-Pro-Pro tripeptide-containing milk product has acute blood pressure lowering effects in mildly hypertensive subjects.
    Turpeinen AM; Ehlers PI; Kivimäki AS; Järvenpää S; Filler I; Wiegert E; Jähnchen E; Vapaatalo H; Korpela R; Wagner F
    Clin Exp Hypertens; 2011; 33(6):388-96. PubMed ID: 21649532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.